Anal Cancer - Pipeline Review, Q4 2010

Global Markets Direct, December 2010, Pages: 37

Anal Cancer - Pipeline Review, Q4 2010

Summary

Global Markets Direct’s, “Anal Cancer Pipeline Review, Q4 2010”, provides an overview of the Anal Cancer therapeutic pipeline. This report provides information on the therapeutic development for Anal Cancer , complete with latest updates, and special features on late-stage and discontinued projects. It also reviews key players involved in the therapeutic development for Anal Cancer . “Anal Cancer -Pipeline Review 2010, Q4 2010” is built using data and information sourced from Global Markets Direct’s proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct’s team.

Scope

- A snapshot of the global therapeutic scenario for Anal Cancer   .
- A review of the Anal Cancer    products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Anal Cancer    pipeline on the basis of therapeutic class, route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

Reasons to buy

- A snapshot of the global therapeutic scenario for Anal Cancer   .
- A review of the Anal Cancer    products under development by companies and universities/research institutes based on information derived from company and industry-specific sources.
- Coverage of products based on various stages of development ranging from discovery till registration stages.
- A feature on pipeline projects on the basis of monotherapy and combined therapeutics.
- Coverage of the Anal Cancer    pipeline on the basis of therapeutic class, route of administration and molecule type.
- Profiles of late-stage pipeline products featuring sections on product description, mechanism of action and research & development progress.
- Key discontinued pipeline projects.
- Latest news and deals relating to the products.

List of Tables
List of Figures
Introduction
Global Markets Direct Report Coverage
Anal Cancer Overview
Therapeutics Development
An Overview of Pipeline Products for Anal Cancer
Anal Cancer Therapeutics under Development by Companies
Anal Cancer Therapeutics under Investigation by Universities/Institutes
Late Stage Products
Comparative Analysis
Mid Clinical Stage Products
Comparative Analysis
Early Clinical Stage Products
Comparative Analysis
Pre-Clinical Stage Products
Comparative Analysis
Companies Involved in Anal Cancer Therapeutics Development
PDS Biotechnology Corporation
Universities/Institutes Involved in Anal Cancer Therapeutics Development
Anal Cancer Therapeutics Assessment
Assessment by Monotherapy Products
Assessment by Combination Products
Assessment by Route of Administration
Assessment by Molecule Type
Late Stage Drug Profiles – Universities/Institutes
5-Fluorouracil + Cisplatin + Radiation Therapy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
cisplatin + fluorouracil + mitomycin C + radiation therapy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Cisplatin + Fluorouracil + Radiation Therapy - Drug Profile
Product Description
Mechanism of Action
R&D Progress
octreotide acetate - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Rectogesic - Drug Profile
Product Description
Mechanism of Action
R&D Progress
Appendix
Methodology
Coverage
Secondary Research
Primary Research
Expert Panel Validation
Contact Us
Disclaimer

Customers who bought this item also bought

• Nitric Oxide - Therapeutics, Markets and Companies
• Oncology Intelligence: A Comprehensive Report for Decision Making
• Oncology Therapeutics Market in India to 2018 - Introduction of Market-Based Pricing to Fuel Price Wars and Intense Competition Among Domestic and Multinational Players
• Therapeutic Cancer Vaccines Market to 2019 - Pipeline Indicates Safer Treatments and Extended Patient Survival, though High Prices May Limit Uptake
• Brain Tumor – Pipeline Review, H1 2013
• Nausea – Pipeline Review, H1 2013
• Drug Addiction – Pipeline Review, H1 2013
• Ebola Viral Infections – Pipeline Review, H1 2013
• Bone Marrow Transplantation – Pipeline Review, H1 2013
• MicroRNA Diagnostics, Therapeutics, and Cancer Personalized Medicine 2009 Market Report